📌 First-line Dato-DXd vs chemotherapy in pts with locally recurrent inoperable or mTNBC for whom immunotherapy was not an option: Exploratory analysis
✨@RebeccaDSing
#ESMO26 🇪🇸 @OncoAlert #OncoAlertAF